查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600611

臨床試驗供應和物流市場：按服務、按類型、按階段、按治療領域、按最終用戶 - 2025-2030 年全球預測

Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年臨床試驗用品和物流市場的市場規模為243.3億美元，預計2024年將達到262億美元，複合年成長率為7.75%，預計到2030年將達到410.4億美元。

臨床試驗供應和物流市場對於臨床試驗順利、有效率地發展至關重要。該市場包括臨床研究和臨床試驗所需的藥品和醫療材料的供應鏈管理、倉儲、配送和運輸。臨床試驗中對高效物流和供應鏈的需求主要源自於需要遵守嚴格的監管標準、維持藥物完整性以及及時交付至研究機構。該應用程式對於管理跨多個地區的廣泛臨床試驗的製藥公司和委外研發機構(CRO) 至關重要。該應用的最終用途範圍從製藥和生物技術公司到 CRO，甚至是專門從事醫療保健的物流服務提供者。

主要市場統計
基準年[2023] 243.3億美元
預測年份 [2024] 262億美元
預測年份 [2030] 410.4億美元
複合年成長率（%） 7.75%

關鍵的成長要素包括臨床試驗數量的增加，特別是隨著個人化醫療和生技藥品的興起，以及試驗擴展到新興市場。溫控包裝和即時追蹤系統等先進技術的採用正在擴大簡化供應鏈和減少產品浪費的機會。區塊鏈等創新透過人工智慧和機器學習進行預測分析來提高透明度和自動化，具有巨大的潛力。然而，市場也面臨複雜的監管環境、高營運成本以及與低溫運輸管理相關的物流困難等挑戰。

隨著患者數量的增加和監管改革的進展，我們有潛力擴大我們的區域業務，特別是在亞太和拉丁美洲。此外，還有一些領域需要創新，例如改善低溫運輸物流、提高物聯網設備的可見度以及利用資料分析主動管理風險。總之，雖然臨床試驗供應和物流市場存在巨大的成長機會，但必須克服成本壓力和監管挑​​戰等限制。尋求創新和利用這些機會的公司應該投資於技術和策略夥伴關係，以確保他們能夠提供適合臨床試驗不斷發展的性質的高效物流解決方案。

市場動態：揭示快速發展的臨床試驗供應和物流市場的關鍵市場洞察

供需的動態交互作用正在改變臨床試驗供應和物流市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 增加政府資金，以加強慢性病盛行率上升的經濟體的藥物研發活動。
    • 臨床試驗的全球化與法規的統一
  • 市場限制因素
    • 技術整合和資料管理問題
  • 市場機會
    • 整合人工智慧和機器學習以進行供應鏈最佳化中的預測分析
    • 藥廠和 CDMO 之間的夥伴關係活動增加
  • 市場挑戰
    • 臨床試驗供應和物流的業務問題

波特五力：駕馭臨床試驗供應與物流市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解臨床試驗供應和物流市場的外部影響

外部宏觀環境因素在塑造臨床試驗供應和物流市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解臨床試驗用品和物流市場的競爭格局

對臨床試驗用品和物流市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣臨床試驗供應與物流市場供應商的績效評估

FPNV 定位矩陣是評估臨床試驗供應和物流市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 隨著慢性病發病率上升，政府增加資金以加強整個經濟中的藥物研發活動
      • 臨床試驗的全球化與法規的統一
    • 抑制因素
      • 與技術整合和資料管理相關的問題
    • 機會
      • 整合人工智慧和機器學習以進行供應鏈最佳化中的預測分析
      • 藥廠和 CDMO 之間的合作活動增加
    • 任務
      • 與臨床試驗供應和物流業務相關的擔憂
  • 市場區隔分析
    • 服務：低溫運輸配送服務隨著需求的成長而不斷發展
    • 類型：小分子在醫藥領域的使用快速增加
    • 階段：擴大3期臨床試驗供應與物流服務範圍
    • 治療領域：私營和公共部門在腫瘤學方面的投資和研究活動激增
    • 最終用戶：製藥和生物技術公司更多地使用臨床試驗用品和物流
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境
  • 客戶客製化
    • Catalent, Inc.：積極參與網路研討會和會議，推廣臨床試驗供應和物流方面的創新解決方案和服務。
    • Infosys Limited：專注滲透定價策略，以低價提供解決方案，同時確保高精度和高品質
    • Almac 集團：Marken 發起新的行銷宣傳活動以促進臨床藥品的儲存和分銷
    • Eurofins Scientific Group：Eurofins Scientific Group 專注於會議和展覽，以實現有效的產品行銷。
    • Lonza Group AG：Lonza Group AG 加強全球擴張的關鍵數位行銷策略
    • 生物藥品：利用數位技術簡化供應鏈、提高透明度並改善與相關人員的溝通
    • 醫療設備：傳播解決相關人員擔憂的教育內容
    • 小分子：解決激烈競爭和監管複雜性的需要
    • 臨床試驗供應及物流服務採取多元化行銷策略

第6章臨床試驗供應與物流市場：依服務分類

  • 比較採購
  • 物流/配送
    • 低溫運輸運輸
    • 非低溫運輸運輸
  • 製造業
  • 包裝、標籤和致盲
  • 儲存和保留

第7章臨床試驗用品和物流市場：按類型

  • 生物製藥
  • 醫療設備
  • 小分子

第8章臨床試驗供應及物流市場分階段

  • 學士/工學士研究
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第9章依治療領域分類的臨床試驗供應及物流市場

  • 血液疾病
  • 心血管疾病
  • 中樞神經系統和精神障礙
  • 皮膚病
  • 消化系統疾病
  • 耳鼻喉科疾病
  • 免疫學
  • 感染疾病
  • 代謝紊亂
  • 腎臟病學
  • 腫瘤學
  • 罕見疾病
  • 呼吸系統疾病

第10章臨床試驗供應與物流市場：依最終使用者分類

  • 合約調查機構
  • 醫療設備公司
  • 製藥和生物技術公司

第11章美洲臨床試驗供應及物流市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太臨床試驗供應及物流市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲臨床試驗供應及物流市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • PCM Trials 收購荷蘭臨床試驗服務
    • Piramal Pharma Solutions 慶祝在蘇格蘭格蘭奇茅斯開設 ADC 製造廠
    • Biocare 宣布美國擴張作為全球成長策略的一部分
    • Vaxcyte 與 Lonza 簽署新的 PCV 商業製造協議
    • Piramal Pharma Solutions 在艾哈默德巴德的Discovery Services 地點推出體外生物學功能
    • Signant Health 推出 Signant Biotech，以加速和簡化新興生物製藥公司的臨床開發
    • N-SIDE 推出革命性軟體 Lighthouse，塑造全球臨床試驗供應管理的未來
    • Zuellig Pharma 與 GSK 在新加坡建立疫苗分銷中心
    • Alyceum Therapeutics 與 Eurofins CDMO 簽署醫藥多計劃協議
    • Vial宣布與皇家國際集團建立策略夥伴關係
    • Biocair 與 TrakCel 合作提高供應鏈視覺性
    • IDEAYA 擴大與輝瑞的臨床試驗合作和供應協議
    • 康泰倫特開始斥資 2,000 萬美元擴建德國臨床供應設施
    • Eurofins Biopharma 產品測試 ENCO 擴大在美國的產能
    • Calyx推出新的臨床試驗供應預測服務
    • 康泰倫特完成新加坡臨床供應設施擴建，以提高溫度控制能力
    • PAREXEL 在中國蘇州開設臨床試驗用品和物流倉庫

公司名單

  • Acnos Pharma GmbH
  • ADAllen Pharma Ltd
  • Almac Group Limited
  • Ancillare, LP
  • Avantor, Inc.
  • Beroe Holdings Inc.
  • Biocair International Limited
  • Calyx
  • Catalent, Inc.
  • Clinical Services International LTD
  • Clinigen Group PLC
  • COREX LOGISTICS LIMITED
  • DHL Group
  • Eurofins Scientific SE
  • Experic, LLC
  • FedEx Corporation
  • ICON PLC
  • Inceptua SA
  • Infosys Limited
  • IPS Pharma
  • KLIFO A/S
  • Lonza Group AG
  • Marken Limited by United Parcel Service, Inc.
  • Microsoft Corporation
  • Myonex, Inc.
  • N-SIDE SA
  • NUVISAN GmbH
  • OCT Clinical GmbH
  • Octalsoft
  • Parexel International Corporation
  • PCI Pharma Services
  • PHOENIX Pharmahandel GmbH & Co KG
  • Piramal Pharma Limited
  • Recipharm AB
  • SAP SE
  • Sharp Services, LLC
  • Signant Health
  • SIRO Clinpharm Private Limited
  • Thermo Fisher Scientific Inc.
  • Tower Cold Chain Solutions
  • Uniphar PLC
  • Walden Group
  • Zuellig Pharma Pte Ltd by Interpharma Investments Limited
Product Code: MRR-501246436315

The Clinical Trial Supply & Logistics Market was valued at USD 24.33 billion in 2023, expected to reach USD 26.20 billion in 2024, and is projected to grow at a CAGR of 7.75%, to USD 41.04 billion by 2030.

The clinical trial supply and logistics market is critical to ensuring that clinical trials proceed smoothly and efficiently. This market encompasses the supply chain management, warehousing, distribution, and transportation of pharmaceutical goods and medical supplies necessary for clinical research and trials. The necessity for efficient logistics and supply chains in clinical trials primarily stems from the need to adhere to strict regulatory standards, maintain drug integrity, and ensure timely delivery to research sites. This application is vital for pharmaceutical companies and contract research organizations (CROs) that manage extensive trials across multiple geographic regions. Its end-use scope spans pharmaceutical and biotechnology companies, CROs, and even logistics service providers who specialize in healthcare.

KEY MARKET STATISTICS
Base Year [2023] USD 24.33 billion
Estimated Year [2024] USD 26.20 billion
Forecast Year [2030] USD 41.04 billion
CAGR (%) 7.75%

Key growth factors include the increasing number of clinical trials, especially with the rise of personalized medicine and biologics, and the expansion of trials into emerging markets. The adoption of advanced technologies like temperature-controlled packaging and real-time tracking systems has opened opportunities to improve supply chain efficiencies and reduce product wastage. Innovations such as Blockchain for enhancing transparency and automation with AI and machine learning for predictive analytics hold much promise. However, the market also faces challenges such as complex regulatory landscapes, high operational costs, and logistical difficulties associated with cold chain management.

Opportunities lie in the expansion of regional presence, especially in Asia-Pacific and Latin America, due to increasing patient pools and favorable regulatory reform. Furthermore, areas ripe for innovation include improving cold chain logistics, enhancing visibility with IoT-enabled devices, and leveraging data analytics for proactive risk management. In conclusion, while the clinical trial supply and logistics market has significant opportunities for growth, overcoming limitations such as cost pressures and regulatory challenges is vital. Companies aiming to innovate and capitalize on these opportunities should invest in technology and strategic partnerships, ensuring they can offer tailored, efficient logistics solutions for the evolving nature of clinical trials.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Trial Supply & Logistics Market

The Clinical Trial Supply & Logistics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising government funds to strengthen pharmaceutical R&D activities across economies with increasing incidence of chronic diseases
    • Globalization of clinical trials and harmonization of regulations
  • Market Restraints
    • Problems associated with technology integration and data management
  • Market Opportunities
    • Integration of artificial intelligence and machine learning for predictive analytics in supply chain optimization
    • Increasing partnership activities between pharmaceutical manufacturers and CDMOs
  • Market Challenges
    • Concerns associated with the operations within clinical trial supply and logistics

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Trial Supply & Logistics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Trial Supply & Logistics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Trial Supply & Logistics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Trial Supply & Logistics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Trial Supply & Logistics Market

A detailed market share analysis in the Clinical Trial Supply & Logistics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Trial Supply & Logistics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Trial Supply & Logistics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supply & Logistics Market, highlighting leading vendors and their innovative profiles. These include Acnos Pharma GmbH, ADAllen Pharma Ltd, Almac Group Limited, Ancillare, LP, Avantor, Inc., Beroe Holdings Inc., Biocair International Limited, Calyx, Catalent, Inc., Clinical Services International LTD, Clinigen Group PLC, COREX LOGISTICS LIMITED, DHL Group, Eurofins Scientific SE, Experic, LLC, FedEx Corporation, ICON PLC, Inceptua S.A., Infosys Limited, IPS Pharma, KLIFO A/S, Lonza Group AG, Marken Limited by United Parcel Service, Inc., Microsoft Corporation, Myonex, Inc., N-SIDE SA, NUVISAN GmbH, OCT Clinical GmbH, Octalsoft, Parexel International Corporation, PCI Pharma Services, PHOENIX Pharmahandel GmbH & Co KG, Piramal Pharma Limited, Recipharm AB, SAP SE, Sharp Services, LLC, Signant Health, SIRO Clinpharm Private Limited, Thermo Fisher Scientific Inc., Tower Cold Chain Solutions, Uniphar PLC, Walden Group, and Zuellig Pharma Pte Ltd by Interpharma Investments Limited.

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supply & Logistics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Comparator Sourcing, Logistics & Distribution, Manufacturing, Packaging, Labeling, & Blinding, and Storage & Retention. The Logistics & Distribution is further studied across Cold Chain Distribution and Non-Cold Chain Distribution.
  • Based on Type, market is studied across Biologic Drugs, Medical Devices, and Small Molecules.
  • Based on Phase, market is studied across BA/ BE studies, Phase 1, Phase 2, Phase 3, and Phase 4.
  • Based on Therapeutic Area, market is studied across Blood Disorders, Cardiovascular Diseases, CNS & Mental Disorders, Dermatological Disorders, Digestive Disorders, ENT Diseases, Immunology, Infectious Diseases, Metabolic Disorders, Nephrology, Oncology, Rare Diseases, and Respiratory Disorders.
  • Based on End User, market is studied across Contract Research Organisations, Medical Devices Companies, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, Minnesota, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising government funds to strengthen pharmaceutical R&D activities across economies with increasing incidence of chronic diseases
      • 5.1.1.2. Globalization of clinical trials and harmonization of regulations
    • 5.1.2. Restraints
      • 5.1.2.1. Problems associated with technology integration and data management
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of artificial intelligence and machine learning for predictive analytics in supply chain optimization
      • 5.1.3.2. Increasing partnership activities between pharmaceutical manufacturers and CDMOs
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with the operations within clinical trial supply and logistics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Continuous advancements in cold chain distribution services with growing demand
    • 5.2.2. Type: Surging utilization of small molecules in the pharmaceutical sector
    • 5.2.3. Phase: Increasing scope of supply & logistics services in phase 3 clinical trials
    • 5.2.4. Therapeutic Area: Proliferating private and public sector investments and research activities in oncology
    • 5.2.5. End User: Rising use of clinical trial supply & logistics by pharmaceutical & biotechnology companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization
    • 5.5.1. Catalent, Inc. : Active participation in webinars and conferences to promote innovative solutions and services in clinical trial supply and logistics
    • 5.5.2. Infosys Limited: Focus on penetration pricing strategy to provide solution at a low price while ensuring high precision and quality
    • 5.5.3. Almac Group: Launch of new marketing campaign by Marken Limited to promote clinical drug product storage and distribution
    • 5.5.4. Eurofins Scientific Group: Eurofins Scientific Group's focus on conferences and fairs for effective product marketing
    • 5.5.5. Lonza Group AG: Significant digital marketing strategies by Lonza Group AG to enhance their global reach
    • 5.5.6. Biologic Drugs: Utilisation of digital technologies to streamline the supply chain, enhance transparency, and improve communication with stakeholders
    • 5.5.7. Medical Devices: Disseminating educational content addressing stakeholders' pain points
    • 5.5.8. Small Molecules: Need to address intense competition and regulatory complexities
    • 5.5.9. Adoption of diverse marketing strategies for clinical trial supply & logistics services

6. Clinical Trial Supply & Logistics Market, by Services

  • 6.1. Introduction
  • 6.2. Comparator Sourcing
  • 6.3. Logistics & Distribution
    • 6.3.1. Cold Chain Distribution
    • 6.3.2. Non-Cold Chain Distribution
  • 6.4. Manufacturing
  • 6.5. Packaging, Labeling, & Blinding
  • 6.6. Storage & Retention

7. Clinical Trial Supply & Logistics Market, by Type

  • 7.1. Introduction
  • 7.2. Biologic Drugs
  • 7.3. Medical Devices
  • 7.4. Small Molecules

8. Clinical Trial Supply & Logistics Market, by Phase

  • 8.1. Introduction
  • 8.2. BA/ BE studies
  • 8.3. Phase 1
  • 8.4. Phase 2
  • 8.5. Phase 3
  • 8.6. Phase 4

9. Clinical Trial Supply & Logistics Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Blood Disorders
  • 9.3. Cardiovascular Diseases
  • 9.4. CNS & Mental Disorders
  • 9.5. Dermatological Disorders
  • 9.6. Digestive Disorders
  • 9.7. ENT Diseases
  • 9.8. Immunology
  • 9.9. Infectious Diseases
  • 9.10. Metabolic Disorders
  • 9.11. Nephrology
  • 9.12. Oncology
  • 9.13. Rare Diseases
  • 9.14. Respiratory Disorders

10. Clinical Trial Supply & Logistics Market, by End User

  • 10.1. Introduction
  • 10.2. Contract Research Organisations
  • 10.3. Medical Devices Companies
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Clinical Trial Supply & Logistics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Clinical Trial Supply & Logistics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Supply & Logistics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. PCM Trials acquires Netherlands-based Clinical Trial Service
    • 14.3.2. Piramal Pharma Solutions Commemorates Opening of its ADC Manufacturing Expansion in Grangemouth, Scotland
    • 14.3.3. Biocair Announces the U.S. Expansion as Part Of Global Growth Strategy
    • 14.3.4. Vaxcyte and Lonza Sign New Commercial Manufacturing Agreement for PCVs
    • 14.3.5. Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
    • 14.3.6. Signant Health Launches Signant Biotech to Accelerate and Streamline Clinical Development for Emerging Biopharmaceutical Organizations
    • 14.3.7. N-SIDE Introduces Lighthouse, Innovative Software to Shape the Future of Worldwide Clinical Trial Supply Management
    • 14.3.8. Zuellig Pharma and GSK establish vaccine distribution hub in Singapore
    • 14.3.9. Ariceum Therapeutics and Eurofins CDMO Sign a Pharmaceutical Multi-Project Agreement
    • 14.3.10. Vial Announces Strategic Partnership with Royale International Group
    • 14.3.11. Biocair Partners with TrakCel to Improve Visibility in the Supply Chain
    • 14.3.12. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer
    • 14.3.13. Catalent Starts Construction of USD 20M Expansion at Clinical Supply Facility in Germany
    • 14.3.14. Eurofins BioPharma Product Testing ENCO Expands the U.S. Capabilities Footprint
    • 14.3.15. Calyx Introduces New Clinical Trial Supply Forecasting Service
    • 14.3.16. Catalent Completes Expansion of Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities
    • 14.3.17. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China

Companies Mentioned

  • 1. Acnos Pharma GmbH
  • 2. ADAllen Pharma Ltd
  • 3. Almac Group Limited
  • 4. Ancillare, LP
  • 5. Avantor, Inc.
  • 6. Beroe Holdings Inc.
  • 7. Biocair International Limited
  • 8. Calyx
  • 9. Catalent, Inc.
  • 10. Clinical Services International LTD
  • 11. Clinigen Group PLC
  • 12. COREX LOGISTICS LIMITED
  • 13. DHL Group
  • 14. Eurofins Scientific SE
  • 15. Experic, LLC
  • 16. FedEx Corporation
  • 17. ICON PLC
  • 18. Inceptua S.A.
  • 19. Infosys Limited
  • 20. IPS Pharma
  • 21. KLIFO A/S
  • 22. Lonza Group AG
  • 23. Marken Limited by United Parcel Service, Inc.
  • 24. Microsoft Corporation
  • 25. Myonex, Inc.
  • 26. N-SIDE SA
  • 27. NUVISAN GmbH
  • 28. OCT Clinical GmbH
  • 29. Octalsoft
  • 30. Parexel International Corporation
  • 31. PCI Pharma Services
  • 32. PHOENIX Pharmahandel GmbH & Co KG
  • 33. Piramal Pharma Limited
  • 34. Recipharm AB
  • 35. SAP SE
  • 36. Sharp Services, LLC
  • 37. Signant Health
  • 38. SIRO Clinpharm Private Limited
  • 39. Thermo Fisher Scientific Inc.
  • 40. Tower Cold Chain Solutions
  • 41. Uniphar PLC
  • 42. Walden Group
  • 43. Zuellig Pharma Pte Ltd by Interpharma Investments Limited

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COMPARATOR SOURCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COLD CHAIN DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STORAGE & RETENTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BA/ BE STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 1, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 2, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 3, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 4, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ENT DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 132. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 138. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 144. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 145. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 150. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 151. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 153. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 156. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 157. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 159. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 160. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 168. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 169. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 170. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 172. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 173. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 175. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 176. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 178. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 179. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 181. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 182. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 184. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 185. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 187. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 188. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 190. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 191. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 193. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 194. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 196. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 197. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 199. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 200. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 202. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 203. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 204. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 205. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 206. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 208. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 209. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 212. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 214. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 215. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 217. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 218. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 220. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 221. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 223. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 224. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 226. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 227. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 229. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 230. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 232. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 233. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 235. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 236. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 238. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 239. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 240. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 241. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 242. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 244. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 245. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 248. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 250. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 251. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 252. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 254. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 256. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 257. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 259. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 260. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 262. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 263. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 264. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 265. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 266. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 268. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 269. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 272. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 274. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 275. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 276. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 277. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 278. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 280. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 281. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 287. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 288. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 290. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 292. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 293. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 294. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 295. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023